{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:56:42Z","timestamp":1781657802329,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"DOI":"10.1186\/s40959-026-00460-8","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:05:51Z","timestamp":1777503951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Endoscopic ultrasound-guided transoesophageal pericardiocentesis: a case report on a therapeutic solution for pericardial tamponade with malignant posterior pericardial effusion"],"prefix":"10.1186","volume":"12","author":[{"given":"Alfred Chung Pui","family":"So","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Conibear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Januszweski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Manisty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Ricketts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"1","key":"460_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaccao.2019.07.001","volume":"1","author":"A Besnard","year":"2019","unstructured":"Besnard A, Raoux F, Khelil N, et al. Current Management of Symptomatic Pericardial Effusions in Cancer Patients. JACC CardioOncol. 2019;1(1):137\u201340.","journal-title":"JACC CardioOncol"},{"issue":"22","key":"460_CR2","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.1200\/JCO.2005.00.745","volume":"23","author":"HL Gornik","year":"2005","unstructured":"Gornik HL, Gerhard-Herman M, Beckman JA. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol. 2005;23(22):5211\u20136.","journal-title":"J Clin Oncol"},{"issue":"1","key":"460_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/1097-0142(19930101)71:1<93::AID-CNCR2820710115>3.0.CO;2-R","volume":"71","author":"H Okamoto","year":"1993","unstructured":"Okamoto H, Shinkai T, Yamakido M, Saijo N. Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion. Cancer. 1993;71(1):93\u20138.","journal-title":"Cancer"},{"issue":"1","key":"460_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/jcm4010075","volume":"4","author":"BT Li","year":"2014","unstructured":"Li BT, Pearson A, Pavlakis N, et al. Malignant Cardiac Tamponade from Non-Small Cell Lung Cancer: Case Series from the Era of Molecular Targeted Therapy. J Clin Med. 2014;4(1):75\u201384.","journal-title":"J Clin Med"},{"key":"460_CR5","doi-asserted-by":"publisher","first-page":"871132","DOI":"10.3389\/fonc.2022.871132","volume":"12","author":"V Chiruvella","year":"2022","unstructured":"Chiruvella V, Ullah A, Elhelf I, et al. Would the Addition of Immunotherapy Impact the Prognosis of Patients With Malignant Pericardial Effusion? Front Oncol. 2022;12:871132.","journal-title":"Front Oncol"},{"issue":"3","key":"460_CR6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.chest.2023.07.4220","volume":"165","author":"A Kumar","year":"2024","unstructured":"Kumar A, Xu B, Srinivasan D, et al. Long-Term Survival of American Joint Committee on Cancer 8th Edition Staging Descriptors for Clinical M1a Non-Small Cell Lung Cancer. Chest. 2024;165(3):725\u201337.","journal-title":"Chest"},{"issue":"2","key":"460_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jamaoncol.2022.6109","volume":"9","author":"KWC Lee","year":"2023","unstructured":"Lee KWC, Li MSC, Gai W, et al. Testing for EGFR Variants in Pleural and Pericardial Effusion Cell-Free DNA in Patients With Non-Small Cell Lung Cancer. JAMA Oncol. 2023;9(2):261\u20135.","journal-title":"JAMA Oncol"},{"issue":"12","key":"460_CR8","first-page":"100424","volume":"3","author":"M Hibino","year":"2022","unstructured":"Hibino M, Hiranuma O, Takemura Y, et al. Osimertinib and Bevacizumab Cotreatment for Untreated EGFR-Mutated NSCLC With Malignant Pleural or Pericardial Effusion (SPIRAL II): A Single-Arm, Open-Label, Phase 2 Clinical Trial. JTO Clin Res Rep. 2022;3(12):100424.","journal-title":"JTO Clin Res Rep"},{"issue":"1","key":"460_CR9","first-page":"8","volume":"10","author":"S Mori","year":"2024","unstructured":"Mori S, Bertamino M, Guerisoli L, et al. Pericardial effusion in oncological patients: current knowledge and principles of management. Cardiooncology. 2024;10(1):8.","journal-title":"Cardiooncology"},{"issue":"12","key":"460_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/heartjnl-2023-323542","volume":"110","author":"J Lee","year":"2024","unstructured":"Lee J, Kim K, Gwak SY, et al. Pericardiocentesis versus window formation in malignant pericardial effusion: trends and outcomes. Heart. 2024;110(12):863\u201371.","journal-title":"Heart"},{"issue":"1","key":"460_CR11","doi-asserted-by":"publisher","first-page":"100354","DOI":"10.1016\/j.esmoop.2021.100354","volume":"7","author":"LK Chang","year":"2022","unstructured":"Chang LK, Kuo YW, Wu SG, Chung KP, Shih JY. Recurrence of pericardial effusion after different procedure modalities in patients with non-small-cell lung cancer. ESMO Open. 2022;7(1):100354.","journal-title":"ESMO Open"},{"issue":"6","key":"460_CR12","doi-asserted-by":"publisher","first-page":"e002771","DOI":"10.1136\/jitc-2021-002771","volume":"9","author":"J Gong","year":"2021","unstructured":"Gong J, Drobni ZD, Zafar A, et al. Pericardial disease in patients treated with immune checkpoint inhibitors. J Immunother Cancer. 2021;9(6):e002771.","journal-title":"J Immunother Cancer"},{"issue":"6","key":"460_CR13","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.jtho.2019.02.026","volume":"14","author":"M Altan","year":"2019","unstructured":"Altan M, Toki MI, Gettinger SN, et al. Immune Checkpoint Inhibitor-Associated Pericarditis. J Thorac Oncol. 2019;14(6):1102\u20138.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"460_CR14","first-page":"29","volume":"10","author":"SE Mudra","year":"2024","unstructured":"Mudra SE, Rayes DL, Agrawal A, Kumar AK, Li JZ, Njus M, McGowan K, Kalam KA, Charalampous C, Schleicher M, Majid M, Syed A, Yesilyaprak A, Klein AL. Immune checkpoint inhibitors and pericardial disease: a systematic review. Cardiooncology. 2024;10(1):29.","journal-title":"Cardiooncology"},{"issue":"2","key":"460_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jaccao.2019.10.006","volume":"1","author":"K Anand","year":"2019","unstructured":"Anand K, Ensor J, Trachtenberg B, Bernicker EH. Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS). JACC CardioOncol. 2019;1(2):172\u20138.","journal-title":"JACC CardioOncol"},{"issue":"1","key":"460_CR16","first-page":"38","volume":"9","author":"K Patel","year":"2023","unstructured":"Patel K, Hsu KY, Lou K, et al. Osimertinib-induced biventricular cardiomyopathy with abnormal cardiac MRI findings: a case report. Cardiooncology. 2023;9(1):38.","journal-title":"Cardiooncology"},{"issue":"44","key":"460_CR17","doi-asserted-by":"publisher","first-page":"e12751","DOI":"10.1097\/MD.0000000000012751","volume":"97","author":"VR Sundaram","year":"2018","unstructured":"Sundaram VR, Abbas T. Cardiac tamponade induced by dabrafenib and trametinib combination therapy for melanoma: Case report. Med (Baltim). 2018;97(44):e12751.","journal-title":"Med (Baltim)"},{"issue":"42","key":"460_CR18","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Y Adler","year":"2015","unstructured":"Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921\u201364.","journal-title":"Eur Heart J"},{"issue":"40","key":"460_CR19","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","volume":"46","author":"J Schulz-Menger","year":"2025","unstructured":"Schulz-Menger J, Collini V, Gr\u00f6schel J, et al. 2025 ESC Guidelines for the management of myocarditis and pericarditis. Eur Heart J. 2025;46(40):3952\u20134041.","journal-title":"Eur Heart J"},{"issue":"16","key":"460_CR20","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/eurheartj\/ehs372","volume":"34","author":"M Imazio","year":"2013","unstructured":"Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J. 2013;34(16):1186\u201397.","journal-title":"Eur Heart J"},{"issue":"6","key":"460_CR21","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/icvts\/ivu267","volume":"19","author":"GM Jama","year":"2014","unstructured":"Jama GM, Scarci M, Bowden J, Marciniak SJ. Palliative treatment for symptomatic malignant pericardial effusion. Interact Cardiovasc Thorac Surg. 2014;19(6):1019\u201326.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"3","key":"460_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.lungcan.2010.10.013","volume":"72","author":"C Lestuzzi","year":"2011","unstructured":"Lestuzzi C, Bearz A, Lafaras C, et al. Neoplastic pericardial disease in lung cancer: impact on outcomes of different treatment strategies. A multicenter study. Lung Cancer. 2011;72(3):340\u20137.","journal-title":"Lung Cancer"},{"issue":"10","key":"460_CR23","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3390\/curroncol32100568","volume":"32","author":"FJ Mu\u00f1oz-Carrillo","year":"2025","unstructured":"Mu\u00f1oz-Carrillo FJ, Reyes RM, Pes\u00e1ntez D, et al. Retrospective Cohort Study of Intrapericardial Cisplatin for Risk Reduction of Malignant Pericardial Effusion Recurrence. Curr Oncol. 2025;32(10):568.","journal-title":"Curr Oncol"},{"issue":"11","key":"460_CR24","doi-asserted-by":"publisher","first-page":"102346","DOI":"10.1016\/j.jaccas.2024.102346","volume":"29","author":"C Lundahl","year":"2024","unstructured":"Lundahl C, Ejstrud P, Christensen MK. Endoscopic Ultrasound-Guided Transesophageal Pericardiocentesis in the Treatment of Localized Cardiac Tamponade Following Coronary Perforation. JACC Case Rep. 2024;29(11):102346.","journal-title":"JACC Case Rep"},{"issue":"Suppl 1","key":"460_CR25","first-page":"S16","volume":"6","author":"R Bhavani","year":"2017","unstructured":"Bhavani R, Loch A, Hwong-Ruey LA, Hilmi I. P-LUM-18: Beyond the gastrointestinal tract: A case report of an endoscopic ultrasound-guided pericardial drainage. Endosc Ultrasound. 2017;6(Suppl 1):S16.","journal-title":"Endosc Ultrasound"},{"issue":"Suppl 1","key":"460_CR26","first-page":"E71","volume":"48","author":"Y Hashimoto","year":"2016","unstructured":"Hashimoto Y, Inoue K. Endoscopic ultrasound-guided transesophageal pericardiocentesis: an alternative approach to a pericardial effusion. Endoscopy. 2016;48(Suppl 1):E71\u20132.","journal-title":"Endoscopy"},{"issue":"Suppl 3","key":"460_CR27","first-page":"A170","volume":"43","author":"H Yusuke","year":"2011","unstructured":"Yusuke H, Naotaka M, Masaa N. Alternative approach to pericardial effusion: EUS guided transesophageal pericardiocentesis. Endoscopy. 2011;43(Suppl 3):A170.","journal-title":"Endoscopy"},{"key":"460_CR28","doi-asserted-by":"crossref","unstructured":"Dwivedi S, Berg M, Eidem M et al. Endoscopic ultrasound-guided pericardiocentesis in a patient with disseminated cryptococcus infection. Gastrointest Endosc. 2009;69(2):S240.","DOI":"10.1016\/j.gie.2008.12.120"},{"issue":"6","key":"460_CR29","first-page":"e238230","volume":"50","author":"A Loch","year":"2023","unstructured":"Loch A, Teoh VWY, Hilmi IN. A Transesophageal Cardiovascular Intervention. Tex Heart Inst J. 2023;50(6):e238230.","journal-title":"Tex Heart Inst J"},{"issue":"5","key":"460_CR30","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1016\/j.chest.2016.03.013","volume":"150","author":"RK Sharma","year":"2016","unstructured":"Sharma RK, Khanna A, Talwar D. Endobronchial Ultrasound: A New Technique of Pericardiocentesis in Posterior Loculated Pericardial Effusion. Chest. 2016;150(5):e121\u20133.","journal-title":"Chest"},{"issue":"5","key":"460_CR31","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1378\/chest.123.5.1753","volume":"123","author":"L Ceron","year":"2003","unstructured":"Ceron L, Manzato M, Mazzaro F, Bellavere F. A new diagnostic and therapeutic approach to pericardial effusion: transbronchial needle aspiration. Chest. 2003;123(5):1753\u20138.","journal-title":"Chest"},{"issue":"1","key":"460_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1913662","volume":"382","author":"SS Ramalingam","year":"2020","unstructured":"Ramalingam SS, Vansteenkiste J, Planchard D, et al. Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC. N Engl J Med. 2020;382(1):41\u201350.","journal-title":"N Engl J Med"},{"key":"460_CR33","doi-asserted-by":"publisher","first-page":"100592","DOI":"10.1016\/j.lanepe.2023.100592","volume":"27","author":"RGP Gijtenbeek","year":"2023","unstructured":"Gijtenbeek RGP, Damhuis RAM, van der Wekken AJ, Hendriks LEL, Groen HJM, van Geffen WH. Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study. Lancet Reg Health Eur. 2023;27:100592.","journal-title":"Lancet Reg Health Eur"},{"key":"460_CR34","doi-asserted-by":"publisher","first-page":"40374","DOI":"10.1038\/srep40374","volume":"7","author":"D Zhao","year":"2017","unstructured":"Zhao D, Chen X, Qin N, et al. The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer. Sci Rep. 2017;7:40374.","journal-title":"Sci Rep"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-026-00460-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00460-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00460-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:49:59Z","timestamp":1781657399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40959-026-00460-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["460"],"URL":"https:\/\/doi.org\/10.1186\/s40959-026-00460-8","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complied with all relevant ethical regulations as outlined by the Declaration of Helsinki. Verbal and written consent was obtained by the patient before he passed away for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Verbal and written consent was obtained by the patient before he passed away for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}